News Search

Transition delays of more than 60 days between diagnosis and the start of NACT in MIBC care can negatively impact outcomes.

HICCC researchers have found that eIF4G2-dependent protein translation may restrain pancreatic cancer metastasis and help identify aggressive tumors.

Columbia researchers conducted early studies on daraxonrasib, which nearly doubled survival in a landmark clinical trial and has been approved by the FDA for treatment of metastatic pancreatic cancer.

Anil K. Rustgi, MD discusses the warning signs of cancer, the importance of early detection and screening, and practical steps people can take to recognize symptoms and reduce their risk.